Lynn A Raymond
Lynn A Raymond
Professor of Psychiatry, University of British Columbia, Huntington Study Group, Predict-HD
Verified email at
Cited by
Cited by
The Unified Huntington’s Disease rating scale: Reliability and consistency
KK al.
Movement Disorders 11, 136-142, 1996
Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
JS Paulsen, DR Langbehn, JC Stout, E Aylward, CA Ross, M Nance, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 874, 2008
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
RK Graham, Y Deng, EJ Slow, B Haigh, N Bissada, G Lu, J Pearson, ...
Cell 125 (6), 1179-1191, 2006
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease
MM Zeron, O Hansson, N Chen, CL Wellington, BR Leavitt, P Brundin, ...
Neuron 33 (6), 849-860, 2002
Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice
AJ Milnerwood, CM Gladding, MA Pouladi, AM Kaufman, RM Hines, ...
Neuron 65 (2), 178-190, 2010
Extrasynaptic NMDA receptor involvement in central nervous system disorders
MP Parsons, LA Raymond
Neuron 82 (2), 279-293, 2014
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease
Huntington Study Group
Neurology 57 (3), 397-404, 2001
N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
MMY Fan, LA Raymond
Progress in neurobiology 81 (5-6), 272-293, 2007
Rate of functional decline in Huntington’s disease
K Marder, H Zhao, RH Myers, M Cudkowicz, E Kayson, K Kieburtz, ...
Neurology 54 (2), 452-452, 2000
Regulation of ligand-gated ion channels by protein phosphorylation
SL Swope, SJ Moss, LA Raymond, RL Huganir
Advances in second messenger and phosphoprotein research, 49-78, 1999
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
Palmitoylation of huntingtin by HIP14is essential for its trafficking and function
A Yanai, K Huang, R Kang, P Arstikaitis, L Gan, PC Orban, A Mullard, ...
Nature neuroscience 9 (6), 824-831, 2006
Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase
LA Raymond, CD Blackstone, RL Huganir
Nature 361 (6413), 637-641, 1993
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function
LA Raymond, VM André, C Cepeda, CM Gladding, AJ Milnerwood, ...
Neuroscience 198, 252-273, 2011
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease
AJ Milnerwood, LA Raymond
Trends in neurosciences 33 (11), 513-523, 2010
Subtype-dependence of NMDA receptor channel open probability
N Chen, T Luo, LA Raymond
Journal of Neuroscience 19 (16), 6844-6854, 1999
Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity
LA Raymond, CD Blackstone, RL Huganir
Trends in neurosciences 16 (4), 147-153, 1993
Differential sensitivity of RecombinantN-Methyl-d-Aspartate Receptor subtypes to zinc inhibition
N Chen, A Moshaver, LA Raymond
Molecular pharmacology 51 (6), 1015-1023, 1997
Mutant huntingtin enhances excitotoxic cell death
MM Zeron, N Chen, A Moshaver, ATC Lee, CL Wellington, MR Hayden, ...
Molecular and Cellular Neuroscience 17 (1), 41-53, 2001
Wild‐type huntingtin protects neurons from excitotoxicity
BR Leavitt, JM van Raamsdonk, J Shehadeh, H Fernandes, Z Murphy, ...
Journal of neurochemistry 96 (4), 1121-1129, 2006
The system can't perform the operation now. Try again later.
Articles 1–20